BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 557943)

  • 1. Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro.
    Gangadharam PR; Candler ER
    Am Rev Respir Dis; 1977 Apr; 115(4):705-8. PubMed ID: 557943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 4. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activities of riminophenazines.
    Reddy VM; O'Sullivan JF; Gangadharam PR
    J Antimicrob Chemother; 1999 May; 43(5):615-23. PubMed ID: 10382882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antituberculosis and antileprosy drugs on mycobacteriophage D29 growth.
    David HL; Clavel S; Clement F; Moniz-Pereira J
    Antimicrob Agents Chemother; 1980 Aug; 18(2):357-9. PubMed ID: 7447413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
    Yamamoto S; Toida I; Watanabe N; Ura T
    Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of several antileprosy drugs on immunological state of experimental animals.
    Gidoh M; Tsutsumi S; Narita M; Fukushi K
    Nihon Rai Gakkai Zasshi; 1980; 48(4):159-70. PubMed ID: 7380761
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunopharmacology of antileprosy agents.
    Anderson R
    Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
    Seydel JK; Wempe EG
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
    Morrison NE; Collins FM
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of some potential chemotherapeutic compounds.
    Damle P; McClatchy JK; Gangadharam PR; Davidson PT
    Tubercle; 1978 Jun; 59(2):135-8. PubMed ID: 567395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.